Levobupivacaine Medac

Levobupivacaine, the active ingredient in Levobupivacaine Medac, is a local anesthetic (amide type) presented as a sterile solution for epidural, infiltration and intrathecal use. It provides reversible nerve block for surgical and obstetric procedures in adult patients.

GNH USA supplies Levobupivacaine Medac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent manufacturing and distribution protocols to maintain product integrity across global markets, ensuring each batch meets EU regulatory standards.

Levobupivacaine is a local anesthetic used to achieve regional nerve blockade for surgical anesthesia.

- Epidural anesthesia: provides analgesia for labor and postoperative pain management. - Infiltration anesthesia: produces localized numbness for minor surgical procedures. - Intrathecal (spinal) anesthesia: induces sensory block for lower‑body surgeries.

Levobupivacaine may cause a range of adverse reactions.

Common Side Effects: - Hypotension: transient drop in blood pressure. - Bradycardia: slowed heart rate. - Dizziness or light‑headedness. - Nausea or metallic taste.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm. - Seizures: central nervous system excitation. - Prolonged motor block: extended loss of muscle function. - Allergic reaction: rash, itching, or anaphylaxis. - Respiratory depression: reduced breathing effort. - Methemoglobinemia: abnormal hemoglobin levels.

Levobupivacaine should be used with careful clinical assessment.

- Dose adjustment in elderly: reduce volume due to altered pharmacodynamics. - Avoid in patients with known hypersensitivity to amide local anesthetics. - Use cautiously in patients with cardiac conduction disorders. - Monitor cardiovascular status during epidural administration. - Avoid concurrent use with other potent local anesthetics. - Store at controlled room temperature: keep in original packaging, protect from light and moisture.

Levobupivacaine may interact with several drug classes.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): increased risk of cardiotoxicity. - Beta‑blockers: may potentiate bradycardia. - General anesthetics (e.g., propofol) at high doses: additive central nervous system depression.

Moderate Interactions (Monitor Closely): - Opioids administered neuraxially: enhanced respiratory depression. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase bleeding risk. - Magnesium sulfate: may potentiate neuromuscular block.